Juan Carlos Jaume earned his MD from the University of Buenos Aires, Argentina, He received post-doctoral training at the Albert Einstein College of Medicine-Long Island Jewish Medical Center (Internal Medicine Residency) and the University of California, San Francisco (UCSF) (Endocrinology, Diabetes and Metabolism and Molecular Medicine Fellowship Programs). Dr. Jaume was promoted to faculty at UCSF, a position he occupied for a decade until he joined the University of Wisconsin-Madison as the head of the Thyroid Multidisciplinary Clinic and later on Chief of Endocrinology at the Madison VA.  In 2015, the Medical College of Ohio appointed Dr. Jaume as Director of the Center for Diabetes and Endocrine Research (CeDER) and Chief of Endocrinology, Diabetes and Metabolism. He launched the inaugural Endocrinology, Diabetes and Metabolism Fellowship Program and became Director of the MD/PhD Program. Subsequently, Dr. Jaume became Chief of Medicine at the university-affiliated Toledo Hospital. In 2023, Dr. Jaume resumed his VA career as the Chief of Medicine of the Edward Hines, Jr. VA Hospital, and Professor of Loyola University Chicago, Stritch School of Medicine. Dr. Jaume continues to maintain high research productivity, grant funding and support a graduate training profile. He has generated several innovative patents.  One of them (CAR Tregs for Autoimmune and Alloimmune Disorders) has allowed for the creation of the start-up company AdopTracell, Inc. (www.adoptracell.com).